
|Articles|May 12, 2006
Medtronic: For your approval
This is a sample of how your ads will appear around selected BPHcontent. Your ads will be the exclusive content on BPH articles andwill rotate with the other sponsors on General News items.
Advertisement
This is a sample of how your ads will appear around selected BPHcontent. Your ads will be the exclusive content on BPH articles andwill rotate with the other sponsors on General News items.
If you can, please provide up to 150 words to include about your company.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
3
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5








